|Application ||WB, E|
|Calculated MW||37490 Da|
|Antigen Region||127-156 aa|
|Other Names||Cysteine and histidine-rich domain-containing protein 1, CHORD domain-containing protein 1, CHORD-containing protein 1, CHP-1, Protein morgana, CHORDC1, CHP1|
|Target/Specificity||This CHORDC1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 127-156 amino acids from the Central region of human CHORDC1.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||CHORDC1 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Regulates centrosome duplication, probably by inhibiting the kinase activity of ROCK2. Proposed to act as co-chaperone for HSP90. May play a role in the regulation of NOD1 via a HSP90 chaperone complex. In vitro, has intrinsic chaperone activity. This function may be achieved by inhibiting association of ROCK2 with NPM1. Involved in stress response. Prevents tumorigenesis.|
|Tissue Location||Underexpressed in many breast and lung cancers.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
CHORDC1 may be play a role in the regulation of NOD1 via its interaction with HSP90AA1 (By similarity).
Gano, J.J., et al. Mol. Cell Proteomics 9(2):255-270(2010)
Lamesch, P., et al. Genomics 89(3):307-315(2007)
Wu, J., et al. FEBS Lett. 579(2):421-426(2005)
Brancaccio, M., et al. FEBS Lett. 551 (1-3), 47-52 (2003) :
Shirasu, K., et al. Cell 99(4):355-366(1999)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.